KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $6.8 billion.

  • Merck's Free Cash Flow fell 1966.38% to $6.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 billion, marking a year-over-year decrease of 1206.87%. This contributed to the annual value of $18.1 billion for FY2024, which is 9792.19% up from last year.
  • Latest data reveals that Merck reported Free Cash Flow of $6.8 billion as of Q3 2025, which was down 1966.38% from $2.5 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Free Cash Flow registered a high of $8.5 billion during Q3 2024, and its lowest value of -$743.0 million during Q4 2023.
  • In the last 5 years, Merck's Free Cash Flow had a median value of $3.2 billion in 2022 and averaged $3.2 billion.
  • In the last 5 years, Merck's Free Cash Flow soared by 254598.54% in 2021 and then tumbled by 12264.55% in 2023.
  • Over the past 5 years, Merck's Free Cash Flow (Quarter) stood at $3.9 billion in 2021, then decreased by 15.59% to $3.3 billion in 2022, then tumbled by 122.65% to -$743.0 million in 2023, then skyrocketed by 438.22% to $2.5 billion in 2024, then soared by 171.99% to $6.8 billion in 2025.
  • Its Free Cash Flow stands at $6.8 billion for Q3 2025, versus $2.5 billion for Q2 2025 and $1.2 billion for Q1 2025.